I nflammation is a central feature in the MRL-Fas
lpr strain with spontaneous autoimmune disease that mimics human systemic lupus erythematosus (1) . Multiple tissues in this strain are targeted for inflammation including kidneys, skin, lungs, glands, and joints. However, most MRL-Fas lpr mice succumb to renal failure (1, 2) . Macrophages (M) 3 are notably abundant in the kidneys of MRL-Fas lpr mice, and following activation mediate renal destruction. M that accumulate in the kidney during inflammation are activated, as reflected by their increased expression of Ia, and enhanced generation of IFN-␥, TNF-␣, and reactive oxygen species (3) (4) (5) (6) . We have established that activated M initiate renal resident cell apoptosis (6, 7) . Therefore, we reason strategies that prevent M recruitment, proliferation, and activation will obviate inflammation and the tissue destruction in the MRL-Fas lpr strain. CSF-1 is a chemotactic survival and proliferation factor for M that is produced by a variety of renal resident cells including tubular epithelial cells (TEC), mesangial cells, and fibroblasts (8 -10) . CSF-1 is closely linked to the pathogenesis of lupus nephritis in MRL-Fas lpr mice. This is based on our prior findings that 1) CSF-1 in the serum and CSF-1 mRNA transcripts in the kidney cortex are evident in advance of overt renal pathology in MRLFas lpr mice, and continue to rise with advancing nephritis (11, 12) ; 2) renal resident cells, in particular TEC, are a primary source of CSF-1 in the kidney (13, 14) ; 3) gene transfer of CSF-1 into the kidney of lpr strains recruits M and autoreactive T cells, thereby initiating nephritis (15); 4) intrarenal CSF-1 production is dependent on a stimulant in the circulation of MRL-Fas lpr mice with nephritis (12, 13) ; and 5) CSF-1 recruits and regulates M proliferation, and is required for M activation, and in turn, renal resident cell apoptosis (6) . Based on this evidence, we hypothesized M-mediated lupus nephritis, and the systemic illness will be suppressed in MRL-Fas lpr mice lacking CSF-1. The recessive mutation, osteopetrotic (Csf1 op ), is an inactivating mutation in the mouse CSF-1 gene (16 -18) . Csf1 op /Csf1 op mice are CSF-1-deficient (17, 18) . To eliminate CSF-1 in the MRLFas lpr strain, we introduced the Csf1 op mutation onto the MRLFas lpr background and generated Csf1 op /Csf1 op mice by breeding. We now report that CSF-1-deficient MRL-Fas lpr mice are protected from lupus nephritis, and the systemic illness. We have determined that CSF-1 has a broad spectrum of actions in the MRL-Fas lpr strain. CSF-1 mediates M, T cell, and B cell functions that are instrumental in the pathogenesis of in MRL-Fas lpr mice. Taken together, CSF-1 is a potential therapeutic target to combat lupus nephritis, and the systemic illness in humans. op or ϩ/ϩ) mice on the C57BL/6J ϫ C3Heb/FeJ-a/a background were purchased from The Jackson Laboratory (Bar Harbor, ME). These mice were housed and bred in our pathogen-free animal facility.
Materials and Methods

Mice
Generating CSF-1-deficient MRL-Fas lpr mice
We constructed CSF- We evaluated the CSF-1-deficient and CSF-1-intact MRL-Fas lpr mice at N3 for several reasons. In experiments in which the Csf1 op mutation was backcrossed onto C57BL/6J, C3H/HeJ, and FVB/NJ strain for five generations the only viable homozygous mutant progeny obtained with our routine powdered chow and care were on the FVB/NJ strain background. In our initial attempts to introduce the mutation onto the MRL-Fas lpr background, we encountered a loss of viability of the Csf1 op /Csf1 op mice at a backcross generation of N4 (our unpublished observation). We attributed this to a loss of modifier genes that enhance survival of CSF-1-deficient mice during the backcrossing. Because our prior studies using wild-type mice of other strains backcrossed to MRL-Fas lpr for three generations indicated that their phenotype was similar to the MRL-Fas lpr strain (22-24), we evaluated the CSF-1-deficient MRL-Fas lpr mice at the N3 backcross generation. Importantly, the lupus susceptibility loci are located on chromosomes 4, 5, 7, and 10 (25) and therefore are expected to segregate independently of the Csf-1 gene located on chromosome 3. Thus, the Csf-1 deficiency mutation can be introduced into MRL-Fas lpr mice with minimal effect on the background of disease related genes.
We entered 17 CSF-1-deficient MRL-Fas lpr mice and 35 CSF-1-intact MRL-Fas lpr mice into the protocol. We evaluated nearly equal proportions of females and males in the CSF-1-deficient and -intact MRL-Fas lpr strains (55 and 63%, respectively). In all experiments, we compared equal proportions of females and males in the CSF-1-deficient with intact MRLFas lpr strains. Because the 50% mortality of the intact MRL-Fas lpr mice at the N3 generation is extended by ϳ2 mo compared with the MRL-Fas lpr mice to which they were backcrossed, pathology was evaluated at 6 and/or 8 mo of age.
Histopathology
Renal. We fixed kidneys in 10% formalin for 24 h, and stained paraffin sections (4 m) with periodic acid Schiff reagent. We evaluated kidney pathology as previously described (26) . Briefly, glomerular pathology was assessed by examining 20 glomerular cross-sections (gcs) per kidney and scoring each glomerulus on a semiquantitative scale: 0 ϭ normal (35-40 cells/gcs); 1 ϭ mild (glomeruli with few lesions showing slight proliferative changes, mild hypercellularity (41-50 cells/gcs), and/or minor exudation; 2 ϭ moderate (glomeruli with moderate hypercellularity (51-60 cells/ gcs), including segmental and/or diffuse proliferative changes, hyalinosis, and moderate exudates); and 3 ϭ severe (glomeruli with segmental or global sclerosis and/or severe hypercellularity (Ͼ60 cells/gcs), necrosis, crescent formation, and heavy exudation). Interstitial/tubular pathology was assessed semiquantitatively on a scale of 0-3 in 10 randomly selected high power fields (ϫ400). We determined the largest and average number of infiltrates and damaged tubules and adjusted the grading system accordingly: 0 ϭ normal, 1 ϭ mild, 2 ϭ moderate, and 3 ϭ maximum. Perivascular cell accumulation was determined semiquantitatively by scoring the number of cell layers surrounding the majority of vessel walls (score: 0 ϭ none; 1 ϭ Ͻ5; 2 ϭ 5-10; and 3 ϭ Ͼ10). Other tissues. We fixed lung, salivary glands, and lacrimal glands in 10% formalin for 24 h, stained paraffin sections with periodic acid Schiff reagent and evaluated these tissues by light microscopy as previously reported (26) . Perivascular and peribronchiolar leukocyte infiltration were assessed semiquantitatively in 10 random vessels and bronchi, respectively (0 ϭ none; 1 ϭ Ͻ3 layers in Ͻ50%; 2 ϭ 3-6 cell layers in Ͼ50%; 3 ϭ Ͼ6 layers in Ͼ50%). We scored the salivary gland inflammation on a scale of 0-3 (0 ϭ no inflammatory cells); 1 ϭ few perivascular and periductal inflammatory infiltrates (Ͻ100 cells); 2 ϭ moderate number of perivascular and periductal inflammatory infiltrates (100-500 cells); 3 ϭ extensive inflammation with large inflammatory foci (Ͼ500 cells). Lacrimal gland inflammation was scored on a scale of 0-3 (0 ϭ no inflammation; 1 ϭ the presence of at least one focus; 2 ϭ multiple foci; 3 ϭ multiple foci plus evidence of gland destruction).
Blood urea nitrogen (BUN)
We evaluated BUN levels using a colorimetric analysis kit (Urea Nitrogen kit; Sigma-Aldrich, St. Louis, MO) according to manufacturer's instructions. A standard curve was generated and used to determine the concentration of urea nitrogen in the serum samples, which were collected when mice were sacrificed.
Circulating monocytes
Blood monocytes were determined by analyzing whole blood on a Hemavet 850 (Drew Scientific, Portsmouth, RI).
Identifying infiltrating cells
Immunostaining. We stained cryostat-sectioned kidney, spleen, lung, and salivary and lacrimal glands (4 m) for the presence of M with anti-CD68 Ab (Serotec, Oxford, U.K.), T cells with anti-CD4, anti-CD8, and anti-B220 Ab (BD Pharmingen, San Diego, CA), and B cells with anti-CD19 Ab (BD Pharmingen) using the immunoperoxidase staining method, as previously described (27) . Of note, we have previously determined that the B220-positive cells in the MRL-Fas lpr kidney are the unique double negative T cells, and are not B cells (22, 28, 29) . Interstitial M and T cells were determined by counting the number of positive cells in 10 randomly selected high-power fields, glomerular M and T cells were counted in 10 random glomeruli. Flow cytometry. We dissociated kidneys into single cell suspension using mechanical disaggregation. After removing the capsule, kidneys were placed into a small (2.5 cm 2 ) 70-m mesh bag and immersed in 10 ml of PBS. While holding the bag with a pair of forceps, a 1-ml syringe plunger was used to press kidney cells through the mesh bag into the PBS. Cells were collected by centrifugation. RBC were lysed using ACK lysing buffer (BioSource International, Camarillo, CA), and the remaining cells were washed in PBS. FACS buffer (PBS, 5% FBS, and 0.09% NaN 3 ) was used to wash the cells and dilute Ab. We stained these cells with anti-CD68 Ab-FITC, and either anti-inducible NO synthase (iNOS) Ab (BD Transduction Laboratories, San Diego, CA), anti-CD23 Ab-FITC, or anti-CD69 Ab-FITC (eBiosciences, San Diego, CA) for 30 min and analyzed 10,000 cells using FACSCalibur.
Intrarenal proliferating and apoptotic cells
Proliferating cells. To determine the percentage of proliferating leukocytes and TEC we stained paraffin-embedded kidney sections with proliferating cell nuclear Ag (PCNA; DAKO, Carpinteria, CA). Briefly, kidney sections were deparaffinized in xylene (2 ϫ 15 min) then placed in 100% ethanol and rehydrated in decreasing increments of ethanol. Ag retrieval was performed by placing slides in 10 mM sodium citrate buffer (pH 6) and microwaving on high power for 12 min. PCNA was biotinylated and detected on sections by using ARK kit (DAKO) according to manufacturer's instruction. Proliferating tubules were determined by counting the number of positively stained tubules in 10 randomly selected high power fields. The percentage of proliferating leukocytes was determined by dividing the number of proliferating leukocytes by the total number of infiltrating leukocytes per high power field. Apoptotic cells. Apoptotic cells were detected in paraffin embedded kidneys by enzymatic in situ labeling of apoptosis-induced DNA strand breaks (TUNEL method) using TdT FragEL DNA Fragmentation Detection kit (Oncogene, Boston, MA) according to the manufacturer's instructions. The number of TUNEL positive cells were counted in 10 random high-power fields, and categorized as either tubular, or infiltrating cells. The percentage of apoptotic leukocytes was determined by dividing the number of apoptotic leukocytes by the total number of infiltrating leukocytes per highpower field.
IgG and C3 deposits within renal glomeruli
To determine IgG and C3 deposits in the kidney, we incubated cryostatsectioned tissue (4 m) with 20% normal goat serum, followed by FITCconjugated goat anti-mouse IgG and FITC-conjugated goat IgG fraction of mouse C3 (Cappel Laboratory, Malvern, PA) as previously described (26) . The fluorescence intensity within the peripheral glomerular capillary walls and mesangium were scored on a scale of 0 -3 (0 ϭ none; 1 ϭ weak; 2 ϭ moderate; 3 ϭ strong). At least 10 glomeruli per section were analyzed.
Cytokine transcripts in kidney
The expression of MCP-1, IFN-␥, TNF-␣, and RANTES was determined in the renal cortex using real-time, two-step quantitative RT-PCR. Total RNA was isolated from snap-frozen kidney cortexes using TRIzol (Invitrogen Life Technologies, Carlsbad, CA). Residual DNA was removed by treatment with 1 U of DNase I (Invitrogen Life Technologies) at room temperature for 15 min followed by inactivation at 65°C for 10 min. Reverse transcription reaction was performed on 1 mg of RNA using an oligo(dT) primer and Superscript II reverse transcriptase (Invitrogen Life Technologies). Relative quantitation with real-time two-step RT-PCR was performed with SYBR Green PCR Reagents (Qiagen, Valencia, CA) and an ABI PRISM 7700 Sequence Detection System (Applied Biosystems, Foster City, CA), according to the manufacturer's instructions. Reactions were performed using 1.0 l of cDNA at a concentration of 100 ng/ml, in a reaction volume of 25 l. The PCR consists of HotStar Taq activation for 15 min at 95°C, then 40 cycles with heating to 95°C for 15 s and cooling to 60°C for 1 min. The mRNA levels were normalized to those of GAPDH. The PCR primers used were as follows: GAPDH, sense 5Ј-CAT GGC CTC CAA GGA GTA AG-3Ј, antisense 5Ј-CCT AGG CCC CTC CTG TTA TT-3Ј; IFN-␥, sense 5Ј-AAC GCT ACA CAC TGC ATC TTG G-3Ј, antisense 5Ј-GCC GTG GCA GTA ACA GCC-3Ј; MCP-1, sense 5Ј-ACC AGC AAG ATG ATC CCA AT-3Ј, antisense 5Ј-TGT CTG GAC CCA TTC CTT CT-3Ј; TNF-␣, sense 5Ј-TCA GCC GAT TTG CTA TCT CA-3Ј, antisense 5Ј-TGG AAG ACT CCT CCC AGG TA-3Ј; RANTES, sense 5Ј-TGC CAA CCC AGA GAA GAA GT-3Ј, antisense 5Ј-AAG CTG GCT AGG ACT AGA GCA A-3Ј.
Lymphadenopathy, skin lesions, and splenomegaly
We assessed lymphadenopathy and skin lesions monthly beginning at 2 mo of age. Protruding lymph nodes (cervical, brachial, and inguinal) were palpated and scored on a scale of 0 -3 (0 ϭ none; 1 ϭ small, at one site; 2 ϭ moderate, at two different sites; 3 ϭ large, at three or more different sites). Skin lesions were scored by gross pathology: 0 ϭ none; 1 ϭ small (face, ears); 2 ϭ moderate, Ͻ2 cm (face, ears, and back); and 3 ϭ severe, Ͼ2 cm (face, ears, and back). Splenomegaly was determined at the time of sacrifice by comparing the ratios of spleen to body weight.
Serum Igs
We determined total Ig, IgM, IgG1, IgG2a, IgG2b, and IgG3 isotype by ELISA. Plates were coated overnight at 4°C with goat anti-mouse Ig capture Abs (Southern Biotechnology Associates, Birmingham, AL) in PBS. The wells were blocked for 2 h with 3% BSA/PBS. We added Ig standards to the plate, using a series of 3-fold dilutions, and assessed serum samples using serial dilutions starting at 1/100. Standards and serum samples were incubated overnight at 4°C. Bound Ig was detected with goat anti-mouse detection Abs conjugated with HRP (Southern Biotechnology Associates) and detected with tetramethylbenzidine peroxidase substrate (Kirkegaard & Perry Laboratories, Gaithersburg, MD). The absorbance was measured at 450 nm. In addition, anti-dsDNA Ab isotypes (IgG1, IgG2a, IgG2b, and IgG3) in the CSF-1-deficient MRL-Fas lpr and CSF-1-intact MRL-Fas lpr mice were determined at five dilutions as previously reported (30) .
B cell apoptosis in the bone marrow and spleen
Bone marrow cells were isolated by flushing cold HBSS through the femur and tibia, RBC were lysed with ACK lysing buffer (BioSource International) and the cells resuspended in 5% FBS/PBS. Spleen cells were made into a single cell suspension, RBC were lysed and cells resuspended in 5% FBS/PBS. The number of apoptotic B cells was determined by staining cells to identify B cell markers (CD19 or CD45R/B220) and apoptotic cells (Annexin V FITC ; BD Pharmingen). A total of 10,000 cells were analyzed using a flow cytometer.
B cells in the spleen and bone marrow (flow cytometry)
Spleen cells derived from CSF-1-deficient and -intact MRL-Fas lpr mice (21 day of age) were prepared as a single cell suspension, the RBC were lysed, and the splenocytes were resuspended in 5% FBS/PBS. We identified B cells by staining splenocytes with anti-CD19-PE (eBiosciences) for 30 min. Cells (10,000) were analyzed using flow cytometry. Bone marrow and spleen cells were isolated and prepared as previously described from CSF-1-intact MRL-Fas lpr mice (1 mo of age). B cells in the bone marrow and spleen expressing the CSF-1 receptor (c-fms) were detected with CD19-FITC (eBiosciences) and CD115-PE (c-fms) (eBiosciences) and analyzed using flow cytometry.
Statistical analysis
Data are presented as mean Ϯ SEM. We determined statistical significance using Mann-Whitney U test or Student's t test.
Results
Kidney pathology is suppressed in CSF-1-deficient MRL-Fas lpr mice
Tubular/interstitial, glomerular, and perivascular renal pathology is suppressed in CSF-1-deficient as compared with the CSF-1-intact MRL-Fas lpr mice at 6 and 8 mo of age (Fig. 1, a and b) . In the CSF-1-intact MRL-Fas lpr kidneys pathology is notable and consists of leukocyte infiltrates in the interstitium and perivascular area, tubular casts, dilation, atrophy and/or necrosis, and glomerular hypercellularity and crescent formation. In contrast, the leukocyte infiltrates, tubular and glomerular pathology are dramatically suppressed in CSF-1-deficient MRL-Fas lpr kidneys (Fig. 1, a  and b) . However, renal pathology in the CSF-1-deficient MRLFas lpr strain was not entirely prevented because tubular/interstitial, glomerular and perivascular pathology in CSF-1-deficient MRLFas lpr mice was greater than in MRL ϩ/ϩ mice with normal kidneys (Fig. 1a) . Of note, the tempo of renal pathology in the CSF-1-intact MRL-Fas lpr strain at the N3 generation was modestly slower than the wild-type MRL-Fas lpr strain, confirming that there are sufficient MRL background genes at this generation to evaluate the impact of CSF-1 (Fig. 1a) .
BUN, an indicator of renal function, is suppressed in CSF-1-deficient MRL-Fas lpr mice, as compared with the CSF-1-intact MRL-Fas lpr mice at 6 and 8 mo of age (Fig. 1c) . In the absence of CSF-1, the BUN in MRL-Fas lpr did not rise above normal levels (C57BL/6 BUN: 23 Ϯ 2 mg/dl, n ϭ 7; dashed line at 8 mo of age). As the CSF-1-deficient MRL-Fas lpr mice are oliguric, we were unable to collect adequate amounts of urine in a representative number of mice using metabolic cages or the spot urine technique to evaluate urinary protein, or urine creatinine levels. However, because the glomerular architecture remained histologically normal in the CSF-1-deficient MRL-Fas lpr strain, we do not suspect that these mice are proteinuric. Taken together, the CSF-1 deficiency in the MRL-Fas lpr strain suppresses nephritis and protects from a loss of renal function.
Leukocytic infiltrates into the interstitium and glomeruli are suppressed in CSF-1-deficient MRL-Fas lpr kidneys
We have previously determined that M and T cells but not B cells accumulate in the MRL-Fas lpr kidney (22) (23) (24) . The intrarenal T cells consist of CD4, CD8, and unique B220 bearing cells characteristic of the MRL-Fas lpr strain (22) (23) (24) . M (CD68) and T cell (CD4, CD8, and B220) accumulation in the interstitium, glomerular, and perivascular regions are dramatically reduced (ϳ90%) in CSF-1-deficient as compared with CSF-1-intact MRL-Fas lpr mice (Fig. 2) . In fact, the number of leukocytic infiltrates in the CSF-1-deficient MRL-Fas lpr kidneys remained similar to those in normal mice (C57BL/6J). Therefore, CSF-1 is required for M and T cell accumulation in the kidney in the MRL-Fas lpr mice.
Reduced intrarenal leukocytes result from decreased infiltration, reduced intrarenal proliferation, and not increased apoptosis
The reduction in leukocytes in the CSF-1-deficient MRL-Fas lpr kidneys is primarily the result of a decrease in the infiltration of leukocytes in the kidney. In addition, this decrease is, in part, related to a decrease in the percentage of proliferating leukocytes that are recruited into the kidney. We detected 2 Ϯ 0.3% and 7 Ϯ 1% proliferating leukocytes in CSF-1-deficient and CSF-1-intact MRL-Fas lpr kidneys, respectively (n ϭ 5-6 per group, p Յ 0.002).
Conversely, the reduction in leukocytes in CSF-1-deficient MRLFas lpr kidneys was not related to an increase in intrarenal apoptotic leukocytes because the percentage of apoptotic leukocytes in CSF-1-deficient and CSF-1-intact MRL-Fas lpr kidneys was similar (4 Ϯ 1% vs 5 Ϯ 1%, respectively, n ϭ 5-6 per group, p Յ 0.72).
Fewer activated M in CSF-1-deficient MRL-Fas lpr kidneys
Activated M release mediators that induce TEC apoptosis (6, 23) .
We have established that CSF-1 is required for M activation during induced renal inflammation (6) . Thus, the number of activated M in the kidney is a gauge for potential renal damage. CSF-1-deficient MRL-Fas lpr kidneys have fewer activated M (CD69, CD23, iNOS) as compared with the CSF-1-intact kidneys at 6 mo of age. The prevention of M activation was dramatic because the number of activated M in the CSF-1-deficient MRLFas lpr kidney did not increase above normal kidney levels (Fig. 3) . (Fig. 4) . Thus, the absence of CSF-1 suppressed the deposition of Ig and C3 within MRL-Fas lpr glomeruli.
Nephritogenic chemokines/cytokines are suppressed in CSF-1-deficient MRL-Fas lpr kidneys
The accumulation of M and T cells in the kidney is, in part, dependent on key chemoattractant molecules such as MCP-1 and RANTES, which increase during nephritis (23, 34) . We determined that MCP-1 and RANTES transcript expression in the renal cortex is suppressed (86 and 89%, respectively) in CSF-1-deficient MRL-Fas lpr as compared with the CSF-1-intact MRL-Fas lpr mice using real-time PCR (Fig. 5) . In fact, the suppression is so profound that MCP-1 and RANTES transcripts do not exceed normal (C57BL/6J) levels (Fig. 5) . IFN-␥ and TNF-␣ are nephritogenic 
Suppressed TEC apoptosis and proliferation, indices of pathology, in CSF-1-deficient MRL-Fas lpr kidneys
TEC apoptosis and proliferation are features of TEC injury and repair, respectively (37, 38) . We determined that the numbers of apoptotic TEC are decreased (3-fold) in CSF-1-deficient MRLFas lpr mice as compared with the wild-type strain (Fig. 6a) . Similarly, the numbers of proliferating TEC are dramatically decreased (6-fold) in CSF-1-deficient MRL-Fas lpr mice as compared with the wild-type strain (Fig. 6b) . Taken together, these findings further support the concept that in the absence of CSF-1 the kidney is spared from injury.
Systemic pathology, skin lesions, lymphadenopathy, and splenomegaly are suppressed in CSF-1-deficient MRL-Fas lpr mice
CSF-1 has a profound impact on systemic pathology in MRLFas lpr mice evaluated between 2 and 8 mo of age (Fig. 7) . CSF-1-deficient MRL-Fas lpr mice are totally spared from skin lesions (Fig. 7a, upper panel) . Similarly, the spleens (spleen per body weight) are considerably smaller in the CSF-1-deficient MRLFas lpr strain as compared with the CSF-1-intact MRL-Fas lpr strain (Fig. 7b) . In fact, the spleens in CSF-1-deficient MRL-Fas lpr mice are not larger than normal (C57BL/6) spleens. Furthermore, lymphadenopathy mainly consisting of an influx of unique T cells (CD4 Ϫ , CD8 Ϫ , B220 ϩ ) into the lymph node (39, 40) is dramatically suppressed in CSF-1-deficient mice as compared with the CSF-1-intact MRL-Fas lpr strain (Fig. 7a, lower panel) . 
CSF-1-deficient MRL-Fas lpr mice have reduced M, T cells, and B cells in the spleen
The splenomegaly characteristic of MRL-Fas lpr autoimmune disease consists of a huge influx of T cells (unique, CD4, CD8), M, and B cells (41) (42) (43) (44) . The numbers of T cells (CD4, CD8, B220), M (CD68), and B cells (CD19, B220) are reduced in the spleens from the CSF-1-deficient compared with CSF-1-intact MRL-Fas lpr mice as evaluated by immunostaining (Fig. 7c) . Apart from the fact that CD19-bearing B cells are a more mature subset of B220 B cells, B220 is abundantly expressed on the unique T cells in the MRL-Fas lpr mice. Because the increase in spleen size is predominantly due to an influx of these unique T cells, the difference between the CD19 and B220 spleen cells is largely a reflection of these unique T cells. The reduction in splenic B cells (CD19) is evident even in CSF-1-deficient MRL-Fas lpr as compared with wild-type mice at 21 day of age using flow cytometric analysis (33 Ϯ 6%, n ϭ 3 and 47 Ϯ 2%, n ϭ 11, respectively; p Յ 0.03). The reduction in M in the spleen is not reflected in the blood because CSF-1-deficient and -intact MRL-Fas lpr mice have a similar percentage of blood mononuclear cells (9 Ϯ 1%, n ϭ 3 vs 11 Ϯ 1%, n ϭ 9, respectively, p ϭ 0.5) and CD68-positive cells within the mononuclear cell population (19 Ϯ 3%, n ϭ 3 vs 23%, n ϭ 1, respectively).
Leukocyte infiltration into the lung, and salivary and lacrimal glands is suppressed in CSF-1-deficient MRL-Fas lpr mice
Multiple tissues (lung, salivary gland, and lacrimal gland), in addition to kidneys, are targeted for autoimmune destruction in the MRL-Fas lpr strain. Lung infiltrates in the MRL-Fas lpr mice that are predominately M (23), accumulate around the perivascular and peribronchiolar region. We determined that the lung leukocytic infiltrates are drastically reduced (53%) in the CSF-1-deficient as compared with CSF-1-intact MRL-Fas lpr mice (Fig. 8a) . Inflammation in the lacrimal and salivary glands of MRL-Fas lpr mice mimics Sjogren's syndrome, a condition resulting in dry eyes and mouth in humans (45) . Infiltrating leukocytes are focally distributed within these tissues in MRLFas lpr mice. We detected a dramatic reduction in leukocytes in the salivary (83%) and lacrimal glands (94%) in CSF-1-deficient MRL-Fas lpr mice as compared with the wild-type strain (Fig. 8, a and b) . Thus, the lung and lacrimal and salivary glands pathology is mediated by CSF-1 in the MRL-Fas lpr strain.
Serum Ig isotypes are reduced in CSF-1-deficient MRL-Fas lpr mice
Elevated Igs and Ig class switching is a hallmark of autoimmune disease (46, 47) . B cells, responsible for the production of these Abs, are dependent on CSF-1 for survival (48) and differentiation (48, 49) . Therefore, we determined whether the protection from autoimmune disease is associated with suppressed circulating Ig isotypes and/or suppressed autoantibodies. Total IgG and IgM isotypes (IgG1, IgG2a, IgG2b, IgG3, and IgM) are highly suppressed in CSF-1-deficient MRL-Fas lpr by (79, 73, 75, 100, and 67%, respectively, as compared with the CSF-1-intact MRL-Fas lpr mice (Fig. 9a) . To determine whether there was an alteration in autoantigen-specific serum Ig isotypes, we measured the levels of dsDNA-specific Ig subclasses. CSF-1-deficient MRL-Fas lpr mice had reduced levels of serum anti-dsDNA-specific isotypes (IgG1, IgG2a, IgG2b, and IgG3) as compared with CSF-1-intact MRLFas lpr mice (Fig. 9b) . Thus, the amount of circulating Ig isotypes and autoantibodies (dsDNA) isotypes in MRL-Fas lpr mice are dependent on CSF-1.
B cell apoptosis in bone marrow and spleen is increased in CSF-1-deficient MRL-Fas lpr mice
We determined that CD19-positive B cells in the bone marrow and spleen of CSF-1-intact MRL-Fas lpr mice (1 mo of age) express the CSF-1 receptor assessed by flow cytometry (24 Ϯ 5% and 14 Ϯ 4%, respectively, n ϭ 3). Therefore, we tested the hypothesis that B cell survival is altered in CSF-1-deficient as compared with CSF-1-intact MRL-Fas lpr mice. Apoptotic B cells in the bone marrow and spleen are increased in CSF-1-deficient MRL-Fas lpr mice (21 day of age) as compared with age-matched CSF-1-intact MRL-Fas lpr mice (Fig. 10) . Because CSF-1 improves B cell survival in the MRL-Fas lpr and normal strains (48) , the absence of CSF-1 in the CSF-1-deficient MRL-Fas lpr strain may lead to a decrease in B cells and account for the suppression of circulating autoantibodies.
Discussion
The present study indicates that CSF-1 is instrumental in the pathogenesis of lupus nephritis and other tissues targeted for autoimmune injury in the MRL-Fas lpr strain. CSF-1-deficient MRLFas lpr mice are protected from nephritis, and pathology in the systemic tissue (skin, lungs, lacrimal and salivary glands, lymphadenopathy and splenomegaly) as compared with the CSF-1-intact MRL-Fas lpr strain. The extensive accumulation of M and T cells into the interstitium, glomerulus, and perivascular regions of the kidney, and in the lung, lacrimal and salivary glands, and spleen is dramatically suppressed in CSF-1-deficient MRL-Fas lpr strain as compared with the wild-type strain. Minimal renal histopathology in CSF-1-deficient MRL-Fas lpr mice is accompanied by reduced indices of injury and repair including TEC apoptosis and proliferation and nephritogenic chemokines/cytokines. In addition, there is a decrease in circulating Ig isotypes and dsDNA autoantibody isotypes and a reduction in Ig deposits in the renal glomeruli in CSF-1-deficient MRL-Fas lpr mice. This suggests that at least some autoantibodies in the CSF-1-intact mice are dependent on CSF-1. Taken together, CSF-1 mediates a broad spectrum of leukocyte functions that contribute to the pathogenesis of autoimmune disease in the MRL-Fas lpr strain. CSF-1 regulates many biologic functions. CSF-1-deficient mice have a reduction in tissue M in most tissues, are osteopetrotic (due to a paucity of osteoclasts), toothless, poorly fertile, and have a low body weight (17, 50 -52) . The reduced body weight and size of the CSF-1-deficient MRL-Fas lpr strain is related to their smaller skeletal frame that is secondary to abnormal skeletal development. Although CSF-1-deficient MRL-Fas lpr and CSF-1-deficient mice on an outbred background have a higher mortality than wild-type mice (53) , the vast majority of deaths occur within the first month of life and are probably related to skeletal disorders and postweaning adaptation. A similar situation exists on the FVB/NJ background (E. R. Stanley, unpublished observations). Thus, the CSF-1-deficient mice surviving beyond 1 mo, like those used in this study, are quite healthy. For example, CSF-1-deficient mice have normal T cell-dependent and -independent immune responses (54), and the bone marrow cellularity and the osteopetrotic condition largely recovers by 7 mo of life (55) . Therefore, the difference in the phenotype of CSF-1-deficient and CSF-1-intact MRL-Fas lpr strains is not the result of poor health.
Renal disease in the MRL-Fas lpr mice is dependent on infiltrating leukocytes. During renal inflammation induced by ligating the ureter, CSF-1 mediates inflammation and tissue injury(s). We have previously shown that a central mechanism responsible for tissue injury is that following activation, M mediate renal resident cell apoptosis (7) . In this model, CSF-1 is responsible for multiple steps leading to M mediated TEC apoptosis, including 1) M recruitment, 2) M survival and proliferation, and 3) enhancement of M activation (6) . Particularly striking in the present study is the paucity of M and T cells that accumulate in the CSF-1-deficient MRL-Fas lpr kidneys as compared with the wild-type strain. We suggest that a primary mechanism responsible for the intrarenal accumulation of M and T cells is CSF-1-mediated recruitment of leukocytes. We showed previously that implantation of TEC constitutively expressing CSF-1 under the renal capsule fosters an influx of M followed by T cells into the kidney adjacent to the implant in Fas lpr strains, and initiates nephritis (15) . Thus, it follows that in MRL-Fas lpr mice lacking CSF-1, there is a failure to recruit M and T cells into the kidney. In fact, the striking reduction of M and T cells in the MRL-Fas lpr kidney is reminiscent of the protection from leukocytic accumulation in the MCP-1-deficient MRL-Fas lpr strain. In the MCP-1-deficient MRL-Fas lpr mice the accumulation of M and T cells in the MRLFas lpr kidney is almost totally suppressed. Because MCP-1 recruits these leukocytes, but does not regulate proliferation, activation or survival, failed recruitment is totally responsible for the paucity of leukocytes in MCP-1-deficient MRL-Fas lpr kidneys (23) . Thus, CSF-1 and MCP-1 are each necessary, but not sufficient, to recruit leukocytes into the kidney.
Although CSF-1 recruits leukocytes, it is also responsible for intrarenal leukocytic proliferation because we detected a decrease in the percentage of proliferating mononuclear cell infiltrates in the CSF-1-deficient MRL-Fas lpr as compared with wild-type kidneys. Conversely, there was no difference in the percentage of apoptotic mononuclear cell infiltrates in CSF-1-deficient and wild-type MRL-Fas lpr strains. Thus, the survival of leukocytes within the kidney is not altered in CSF-1-deficient MRL-Fas lpr mice. Taken together, this evidence supports the concept that CSF-1-dependent intrarenal leukocyte recruitment and proliferation is responsible for fostering an accumulation of M and T cells in the MRL-Fas lpr kidneys. Parenthetically, it is unlikely that the reduction in leukocyte accumulation in the CSF-1-deficient kidneys is a result of fewer circulating monocytes because we detected similar CD68 and white cell counts in CSF-1-deficient and CSF-1-intact MRLFas lpr strains and by 2 mo of age, the circulating monocyte levels in CSF-1-deficient mice of other strains have been shown to be normal (56) . Similarly, whereas the numbers of M in the kidney during urethal ligation is reduced by treatment with anti-CSF-1 Ab, this reduction is not related to fewer blood monocytes (57) . Because the percentage of activated M is reduced in the CSF-1-deficient vs the wild-type MRL-Fas lpr strain, a reduction in activated M may contribute to diminished M-mediated CSF-1-dependent renal injury. Of note, M and T cell accumulation in the CSF-1-deficient MRL-Fas lpr kidneys destined to spontaneously develop nephritis, is far less than in CSF-1-deficient nonautoimmune surgically induced (ureteral ligation) nephritis. This suggests that CSF-1-regulated recruitment of M and T cells, and CSF-1-mediated M proliferation and activation is more pivotal in initiating and promoting renal disease in the MRL-Fas lpr strain, than in other forms of kidney disease. Taken together, our data suggest that CSF-1-mediated M and T cell recruitment, intrarenal leukocyte proliferation, and M activation is central to the initiating and mediating renal destruction in the MRL-Fas lpr strain. Previous studies have shown that B cell production is suppressed in CSF-1-deficient mice (48, 49) . We now report that CSF-1 directly or indirectly mediates B cells and Ab production in the MRL-Fas lpr strain. This is based on the findings that circulating total Ig, Ig isotypes (G1, G2a, G2b, and G3), anti-dsDNA Ab isotypes (G1, G2a, G2b, and G3), and IgG deposits in the kidney are markedly reduced in CSF-1-deficient MRL-Fas lpr as compared with wild-type mice. It is likely that in the MRL-Fas lpr strain, as in other strains (48, 49) , there are fewer B cells in mice lacking CSF-1. We detected increased B cell apoptosis in the bone marrow and spleen in CSF-1-deficient as compared with CSF-1-intact neonatal MRL-Fas lpr mice. In addition, we detected a reduction in B cells in the spleens of neonates and aged mice (6 mo of age), and a decrease in B cells in the circulation (data not shown). This suggests that B cell survival and autoantibody production in MRLFas lpr mice is dependent, at least in part, on CSF-1. We are not certain whether it is the impact on M, T cells, and/or B cells that is responsible for suppressing lupus nephritis, and the systemic illness in the CSF-1-deficient MRL-Fas lpr strain. This is because the association of lupus nephritis and Ab deposition are not necessarily linked. For example, MCP-1-deficient MRL-Fas lpr mice are spared from the loss of kidney function due to decreased recruitment of leukocytes into the kidney, and yet circulating Abs, and Ig deposits in the kidneys are comparable to those in the MCP-1-intact mice (23) . Similarly, renal disease is protected in ␥-chain-deficient NZB/NZW F 1 hybrid mice despite comparable Ig deposits in glomeruli as compared with the wildtype control mice (58) . In contrast, renal disease is suppressed in B cell-and T cell-deficient MRL-Fas lpr mice (59, 60) . Thus, the CSF-1-dependent mechanism responsible for suppressing lupus nephritis may involve the cellular and/or humoral arm of the immune response apart from direct effects on the recruitment and proliferation of activated M.
The present study indicates that CSF-1 has a broad impact on a spectrum of leukocytic functions that mediate lupus nephritis and the systemic illness in the MRL-Fas lpr strain. The issue remains, whether blocking CSF-1 in patients with lupus offers a therapeutic strategy to combat disease? CSF-1-deficient mice have numerous deleterious features including skeletal abnormalities and poor fertility. However, these appear to be primarily associated with the requirement of CSF-1 during postnatal development, so that CSF-1 is an attractive therapeutic target. Nevertheless, it is possible that blocking CSF-1 may protect from inflammation but lead to consequences that compromise therapy. With this in mind, it is important to dissect the individual roles of the three different CSF-1 isoforms, the cell surface membrane-spanning glycoprotein, the secreted proteoglycan and the secreted glycoprotein. If a particular CSF-1 isoform is responsible for the initiation and progression of lupus in the MRL-Fas lpr strain, more selective therapeutic approaches will be tailored to minimize deleterious consequences.
